144 related articles for article (PubMed ID: 17410286)
1. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.
Grigorescu M; Rusu M; Neculoiu D; Radu C; Serban A; Catanas M; Grigorescu MD
J Gastrointestin Liver Dis; 2007 Mar; 16(1):31-7. PubMed ID: 17410286
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
[TBL] [Abstract][Full Text] [Related]
3. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
[TBL] [Abstract][Full Text] [Related]
5. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
[TBL] [Abstract][Full Text] [Related]
6. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients.
Rossi E; Adams L; Prins A; Bulsara M; de Boer B; Garas G; MacQuillan G; Speers D; Jeffrey G
Clin Chem; 2003 Mar; 49(3):450-4. PubMed ID: 12600957
[TBL] [Abstract][Full Text] [Related]
7. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
Myers RP; Benhamou Y; Imbert-Bismut F; Thibault V; Bochet M; Charlotte F; Ratziu V; Bricaire F; Katlama C; Poynard T
AIDS; 2003 Mar; 17(5):721-5. PubMed ID: 12646795
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
Naveau S; Essoh BM; Ghinoiu M; Marthey L; Njiké-Nakseu M; Balian A; Lachgar M; Prévot S; Perlemuter G
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):404-11. PubMed ID: 24561990
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
[TBL] [Abstract][Full Text] [Related]
10. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
Ngo Y; Munteanu M; Messous D; Charlotte F; Imbert-Bismut F; Thabut D; Lebray P; Thibault V; Benhamou Y; Moussalli J; Ratziu V; Poynard T
Clin Chem; 2006 Oct; 52(10):1887-96. PubMed ID: 16931569
[TBL] [Abstract][Full Text] [Related]
11. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
12. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors.
Imbert-Bismut F; Messous D; Thibault V; Myers RB; Piton A; Thabut D; Devers L; Hainque B; Mercadier A; Poynard T
Clin Chem Lab Med; 2004 Mar; 42(3):323-33. PubMed ID: 15080567
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
14. Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population.
Poynard T; Munteanu M; Deckmyn O; Ngo Y; Drane F; Castille JM; Housset C; Ratziu V; Imbert-Bismut F
J Hepatol; 2012 Sep; 57(3):541-8. PubMed ID: 22612998
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
[TBL] [Abstract][Full Text] [Related]
16. FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.
Salkic NN; Jovanovic P; Hauser G; Brcic M
Am J Gastroenterol; 2014 Jun; 109(6):796-809. PubMed ID: 24535095
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: comparison with hepatitis C.
Leroy V; Sturm N; Faure P; Trocme C; Marlu A; Hilleret MN; Morel F; Zarski JP
J Hepatol; 2014 Jul; 61(1):28-34. PubMed ID: 24631902
[TBL] [Abstract][Full Text] [Related]
18. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
[TBL] [Abstract][Full Text] [Related]
19. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.
Kim BK; Kim SU; Kim HS; Park JY; Ahn SH; Chon CY; Cho IR; Joh DH; Park YN; Han KH; Kim DY
PLoS One; 2012; 7(4):e35825. PubMed ID: 22536445
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection.
Sagrini E; Ardoino I; Marano G; Gianstefani A; Orlandini A; Sebastiani G; Donati G; Cucchetti A; Pelosi G; Ferrari C; Alberti A; Biganzoli E; Piscaglia F; Bolondi L
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1385-95. PubMed ID: 23839163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
